These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19719762)

  • 1. Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?
    Mooij CF; Kroese JM; Claahsen-van der Grinten HL; Tack CJ; Hermus AR
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):137-46. PubMed ID: 19719762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular health, growth and gonadal function in children and adolescents with congenital adrenal hyperplasia.
    Mooij CF; Webb EA; Claahsen van der Grinten HL; Krone N
    Arch Dis Child; 2017 Jun; 102(6):578-584. PubMed ID: 27974295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity.
    Van Gaal LF
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S142-8. PubMed ID: 16863690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Reisch N; Arlt W; Krone N
    Horm Res Paediatr; 2011; 76(2):73-85. PubMed ID: 21597280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues.
    Ogilvie CM; Crouch NS; Rumsby G; Creighton SM; Liao LM; Conway GS
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):2-11. PubMed ID: 16402922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital adrenal hyperplasia - how to improve the transition from adolescence to adult life.
    Kruse B; Riepe FG; Krone N; Bosinski HA; Kloehn S; Partsch CJ; Sippell WG; Mönig H
    Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):343-55. PubMed ID: 15239019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult congenital adrenal hyperplasia.
    Bozzola M
    Horm Res; 2007; 68 Suppl 5():154. PubMed ID: 18174735
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term cardio-metabolic outcomes in patients with classical congenital adrenal hyperplasia: is the risk real?
    Gomes LG; Mendonca BB; Bachega TASS
    Curr Opin Endocrinol Diabetes Obes; 2020 Jun; 27(3):155-161. PubMed ID: 32304389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Menstrual and reproductive function in patients with congenital adrenogenital syndrome and long-term steroid hormone treatment].
    Bakhratova TP; Bogdanova EA; Kotliarskaia EI
    Sov Med; 1977 Jun; (6):87-91. PubMed ID: 897787
    [No Abstract]   [Full Text] [Related]  

  • 11. Congenital adrenal hyperplasia: adolescence and transition.
    Conway GS
    Horm Res; 2007; 68 Suppl 5():155-7. PubMed ID: 18174736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis.
    Tamhane S; Rodriguez-Gutierrez R; Iqbal AM; Prokop LJ; Bancos I; Speiser PW; Murad MH
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4097-4103. PubMed ID: 30272185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteocalcin in congenital adrenal hyperplasia.
    Lisá L; Neradilová M; Tomásová N; Soutorová M; Zimák J
    Bone; 1995 Jan; 16(1):57-9. PubMed ID: 7742084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term consequences of childhood-onset congenital adrenal hyperplasia.
    White PC; Speiser PW
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):273-88. PubMed ID: 12064893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia.
    Barbot M; Mazzeo P; Lazzara M; Ceccato F; Scaroni C
    Front Endocrinol (Lausanne); 2022; 13():934675. PubMed ID: 35979433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital adrenal hyperplasia: Results of medical therapy on appearance of external genitalia.
    Kulshreshtha B; Khadgawat R; Eunice M; Ammini AC
    J Pediatr Urol; 2010 Dec; 6(6):555-9. PubMed ID: 20117057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
    Hauffa BP; Winter A; Stolecke H
    Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal dexamethasone treatment of fetuses at risk for congenital adrenal hyperplasia: benefits and concerns.
    Ritzén EM
    Semin Neonatol; 2001 Aug; 6(4):357-62. PubMed ID: 11972437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term medical comorbidities and their management: hypertension/cardiovascular disease.
    Guckelberger O
    Liver Transpl; 2009 Nov; 15 Suppl 2():S75-8. PubMed ID: 19877022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.